RxDoctor Payments Data

Maria Maloto

Nurse Practitioner · Naperville, ILNPI 1386165413

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $117,990 of the $134,774 with a category attached, or 87.5%. AbbVie accounts for 99.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $39,931 and has fallen 63.3% since, to $14,654 in 2025. Among nurse practitioner clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$134,774in general payments, 2019–2025

Across 233 payments — averaging $578.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$134K
  • Galderma Laboratories, L.p.$313
  • Revance Therapeutics, Inc.$60

What the payments were for

  • Speaking & faculty fees$117,99088%
  • Travel & lodging$11,4749%
  • Food & beverage$5,2594%
  • Education$510%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)218$134,401
Galderma Laboratories, L.p.13$313
Revance Therapeutics, Inc.2$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$134,774 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Other nurse practitioner in Naperville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →